NCT Number: NCT00564291
Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)
Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–100 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Dep. Ophthalmology, University Hospital Bern, Bern, Switzerland
About this study
Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Macular disease
- Healthy subjects
Treatment and study plan
Primary outcomes
-
Integrity of retinal layers
Time frame: End of study
Sponsors and collaborators
Lead sponsor
Sebastian Wolf
Other
Collaborators
- University of Bern
Registry information
Official study title
Evaluation of Retinal Structure With High Resolution OCT
Important dates
- Study start
- 2007
- Primary completion
- 2023
- Study completion
- 2023
- First posted
- Nov 27, 2007
- Registry last updated
- Nov 29, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
NCT06011798
Cardiovascular Diseases, Diabetes Complications
Bakersfield, California, United States
View Trial DetailsComparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period
NCT07090044
Cardiovascular Diseases, Choroid Diseases
St Louis, Missouri, United States
View Trial DetailsA Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients
NCT04635800
Cardiovascular Diseases, Diabetic Macular Edema
Huntington Beach, California, United States
View Trial DetailsTargeted Laser in Diabetic Macular Edema
NCT03751501
Cardiovascular Diseases, Diabetes Complications
Paris, France
View Trial Details